Combat exposure, irregular schedules, and physical demands create specific hormone optimization needs
10 As of early 2023, available evidence generally lends support to a preferred approach to menopausal hormone therapy beginning within 10 years of menopause and comprising transdermal estradiol along with oral micronized progesterone for the management of vasomotor symptoms
A 70-year-old subject with normal age-adjusted GFR (6070 mL/min/1.73m) will clear GHK-Cu 2030% slower than a 25-year-old with GFR above 90
What it does cover: the pharmacological rationale some practitioners cite for combining these compounds, the absorption and timing issues that matter if you're already taking both, and the specific scenarios where glutathione might theoretically address metabolic stress during rapid weight loss
Aging Cell 9 , 722735 (2010)
392: s325 DOI: 10.1136/bmj.s325 Cite This Page : ScienceDaily